Association between glutathione peroxidase-1 (GPX1) Rs1050450 polymorphisms and cancer risk.
Chengdi Wang(Sichuan University), Weimin Li(Sichuan University), Yan Sun(Wenzhou Medical University), Lan Yang(China University of Mining and Technology), Yinsu Wang(Sichuan University), Yulin Ji(West China Hospital of Sichuan University), Rui Zhang(Central South University of Forestry and Technology), Nan Chen(Boston Children's Hospital), Min Zhu(Army Medical University), Lin Huang(Sun Yat-sen University)
PubMed
January 1, 2017
Cited by 18
Related Papers
Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050
|JAMA Oncology|2023|822
Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation
|Journal of Thoracic Oncology|2015|682
The signal pathways and treatment of cytokine storm in COVID-19
|Signal Transduction and Targeted Therapy|2021|615
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
|Nature Immunology|2021|422
Ionizable lipid nanoparticles for in utero mRNA delivery
|Science Advances|2021|220